Skip to main content

Find Clinical Trials

Home
Conditions
Uveal Melanoma

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

74 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Completed

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

NCT03652077

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +96 more
Locations: The Angeles Clinical and Research Institute Los Angeles, California, United States

University of Mississippi Jackson, Mississippi, United States

Hackensack Medical Center Hackensack, New Jersey, United States

Carolina BioOncology Huntsville, North Carolina, United States

View Trial Details

Completed

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

NCT01430416

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: Dana Farber Cancer Institute DFCI - Brookline Boston, Massachusetts, United States

Memorial Sloan Kettering MSKCC 4 New York, United States

Novartis Investigative Site Paris, France

Novartis Investigative Site Leiden, Netherlands

View Trial Details

Completed

Uveal Melanoma and Brachytheraphy: Long-term Outcomes.

NCT04577742

Conditions: 106 Ruthenium Plaque Brachytherapy, Eye Diseases, Eye Neoplasms, +12 more
Locations: University of Naples "Federico II" Naples, Italy

View Trial Details

Completed

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

NCT02771340

Conditions: Choroid Diseases, Choroid Neoplasm, Choroid Neoplasms, +14 more
Locations: San Francisco, California, United States

Denver, Colorado, United States

Leawood, Kansas, United States

Boston, Massachusetts, United States

View Trial Details

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center Rockledge, Pennsylvania, United States

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

NCT01034787

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma

NCT01252251

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

NCT01974752

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations: Research Site Los Angeles, California, United States

Research Site Aurora, Colorado, United States

Research Site Atlanta, Georgia, United States

Research Site Lutherville, Maryland, United States

View all 31 locations

View Trial Details

Completed

Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

NCT00351728

Conditions: Choroidal Melanoma, Eye Diseases, Eye Neoplasms, +13 more
Locations: Jules Stein Eye Institute Los Angeles, California, United States

View Trial Details

Completed

Treatment With Intravitreal Avastin for Large Uveal Melanomas

NCT00596362

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details